News

September 26, 2018
September 26, 2018

GENEWIZ to be Acquired by Brooks Automation for $450 Million

Do you like it?
Read more
September 4, 2018
September 4, 2018

Key Biologics and Blood Centers of America Partner to Advance Cell Therapy and Regenerative Medicine

Do you like it?
Read more
September 4, 2018
September 4, 2018

Ampersand Invests in Management Buyout of Clinical Immunology Provider NEOMED-LABS from the NEOMED Institute

Do you like it?
Read more
August 9, 2018
August 9, 2018

Key Biologics and Astarte Biologics Merge

Do you like it?
Read more
June 14, 2018
June 14, 2018

Sarepta Therapeutics Enters into Long-term Strategic Manufacturing Partnership with Brammer Bio to Support Gene Therapy Development and Commercial Supply

Do you like it?
Read more
June 4, 2018
June 4, 2018

MolecularMD and Genoptix Enter into a Definitive Agreement to Market the MRDx® BCR-ABL Test, a Companion Diagnostic for Treatment-free Remission in Ph+ CML-CP Patients Treated with Tasigna®

Do you like it?
Read more
March 26, 2018
March 26, 2018

LakePharma Appoints David Boyle To Chief Financial Officer

Do you like it?
Read more
March 26, 2018
March 26, 2018

Ampersand Announces Successful Exit of CutisPharma

Do you like it?
Read more
March 26, 2018
March 26, 2018

MedPharm Receives Growth Equity Investment from Ampersand Capital Partners

Do you like it?
Read more
March 20, 2018
March 20, 2018

Brammer Bio Expands Leadership Team for Commercial Readiness

Do you like it?
Read more
Prev page
12345...10
Next page